We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2024-05-30 09:01:002024-05-30 09:01:03Four sites open in France: CHU Brest, CHU Dijon, Hospital Edouard Herriot in Lyon and CHU St. Etienne.
https://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.png00mpelusohttps://www.safesspe.ch/wp-content/uploads/sites/5/2020/05/safesspe-logo-400x82px-300x62.pngmpeluso2024-03-22 13:35:562024-03-28 13:39:01Second site in France, the university hospital in St. Étienne, was initiated and will soon start with patient recruiting.
We are happy to announce that the Ottawa Hospital in Canada enrolled the first study participant on 8th of November 2023. Congratulation to the study team!
Four sites open in France: CHU Brest, CHU Dijon, Hospital Edouard Herriot in Lyon and CHU St. Etienne.
We are happy to annouce that 3 additional sites beside CHU Brest could be initiated in April and May 2024. We wish the study teams at all four sites good luck for recruiting of trial participants!
Second site in France, the university hospital in St. Étienne, was initiated and will soon start with patient recruiting.
We wish the study team good luck!
First patient recruited in Ottawa (CA)!
We are happy to announce that the Ottawa Hospital in Canada enrolled the first study participant on 8th of November 2023. Congratulation to the study team!